CClinicalTrials.gg
Not yet recruitingNCT07805772ILEXUpdated Sep 4, 2026

Effects of Different Exercise Types on Irisin, Leptin, and Ghrelin Levels in Sedentary Women

An interventional study of Aerobic Exercise and Anaerobic Exercise in Exercise Physiology and Metabolic Hormones, sponsored by Inonu University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Inonu University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 24 Years
Sex
Female
01

Study summary

This interventional study aims to investigate the acute effects of three different exercise modalities-aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT)-on irisin, leptin, and ghrelin levels in sedentary women. A total of 20 sedentary women will participate in the study. Hormonal responses will be evaluated in relation to the exercise sessions to determine exercise-induced changes in irisin, leptin, and ghrelin and to compare the responses associated with the three exercise modalities.

Read the detailed description

This interventional study is designed to investigate and compare the acute effects of aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT) on irisin, leptin, and ghrelin levels in sedentary women. A total of 20 sedentary women will participate in the study.

Participants will complete three different exercise conditions: aerobic exercise, anaerobic exercise, and HIIT. Irisin, leptin, and ghrelin levels will be evaluated in relation to each exercise condition to determine acute exercise-induced hormonal responses. The study will compare changes in these biomarkers across the three exercise modalities to determine whether the hormonal responses differ according to exercise type.

The study is intended to provide a better understanding of the acute endocrine and metabolic responses to exercise modalities with different physiological demands in sedentary women, with particular emphasis on irisin, leptin, and ghrelin.

02

Conditions studied

  • Exercise Physiology
  • Metabolic Hormones

Keywords

  • Irisin
  • Leptin
  • Ghrelin
  • Sedentary Women
03

Who can participate

Ages eligible
18 Years to 24 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Female participants Sedentary individuals Voluntary participation in the study Ability and willingness to complete the planned exercise sessions

Exclusion Criteria: Inability to participate in the planned exercise sessions Withdrawal of consent or unwillingness to continue participation

04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Multiple Exercise Modalities

    Participants in this arm will complete three different exercise conditions in separate sessions: aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT). Irisin, leptin, and ghrelin levels will be assessed in relation to each exercise condition to evaluate and compare acute hormonal responses across the three exercise modalities.

    Behavioral: Aerobic Exercise · Behavioral: Anaerobic Exercise · Behavioral: High-Intensity Interval Training (HIIT)

Interventions

  • BehavioralAerobic Exercise

    Participants will complete an aerobic exercise session as one of the three exercise conditions. Irisin, leptin, and ghrelin levels will be assessed in relation to the exercise session to determine the acute hormonal response to aerobic exercise.

  • BehavioralAnaerobic Exercise

    Participants will complete an anaerobic exercise session as one of the three exercise conditions. Irisin, leptin, and ghrelin levels will be assessed in relation to the exercise session to determine the acute hormonal response to anaerobic exercise.

  • BehavioralHigh-Intensity Interval Training (HIIT)

    Participants will complete a high-intensity interval training (HIIT) session as one of the three exercise conditions. Irisin, leptin, and ghrelin levels will be assessed in relation to the exercise session to determine the acute hormonal response to HIIT.

05

What researchers measure

Primary outcomes

  1. Change in Irisin Level

    Irisin levels will be assessed in relation to each exercise condition to determine the change in circulating irisin levels associated with aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT)

    Time frame: Pre-exercise and immediately post-exercise during each exercise session

  2. Change in Leptin Level

    Leptin levels will be assessed in relation to each exercise condition to determine the change in circulating leptin levels associated with aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT).

    Time frame: Pre-exercise and immediately post-exercise during each exercise session

  3. Change in Ghrelin Level

    Ghrelin levels will be assessed in relation to each exercise condition to determine the change in circulating ghrelin levels associated with aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT).

    Time frame: Pre-exercise and immediately post-exercise during each exercise session

06

Study locations

1 site
  • Exercise Physiology Laboratory, Faculty of Sport Sciences, Karabuk University
    Karabük, Karabük Province, Turkey (Türkiye)
07

References and documents

Individual participant data

Plan to share: No — There is no plan to make individual participant data (IPD) available to other researchers.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07805772
Lead sponsor
Inonu University
Responsible party
Assoc. Prof. Dr. Özgür EKEN (Assoc. Prof.Dr., Inonu University) — Principal investigator
First posted
Sep 4, 2026
Start date
Sep 5, 2026 (estimated)
Primary completion
Sep 25, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Sep 4, 2026

Study contacts

Özgür EKEN, PhD
Contact
ozgur.eken@inonu.edu.tr
+905532132795

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion